Nascent Biotech, Inc. (NBIO)

Nascent Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 16, 2026	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	0	31	7	6	6	12
Market Cap Growth	-99.66%	338.51%	13.54%	-0.40%	-47.12%	122.34%
Enterprise Value	-	31	7	6	6	12
Last Close Price	0.00	0.18	0.06	0.06	0.06	0.27
PS Ratio	-	-	-	6.31	8.45	-
PB Ratio	-0.10	-122.36	-5.53	-9.39	-13.40	-4.16
P/OCF Ratio	-	-	-	15.26	-	-
EV/Sales Ratio	-	-	-	6.47	8.52	-
Debt / Equity Ratio	-0.11	-0.48	-0.30	-	-0.34	-0.05
Net Debt / Equity Ratio	-0.02	0.97	-0.17	0.14	-0.34	-0.05
Asset Turnover	-	-	-	2.33	1.99	-
Quick Ratio	0.06	0.46	0.11	0.12	0.61	0.00
Current Ratio	0.31	0.68	0.16	0.14	0.61	0.00
Return on Assets (ROA)	-854.34%	-345.34%	-747.66%	-66.68%	-231.96%	-3199.30%
Return on Capital Employed (ROCE)	406.90%	868.80%	166.30%	68.10%	296.40%	119.90%
Earnings Yield	-3712.12%	-6.65%	-39.11%	-7.46%	-15.14%	-33.43%
Buyback Yield / Dilution	-30.53%	-31.35%	-10.05%	-48.93%	-110.34%	-14.30%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2024

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 17, 2026

Data Sources Report a data error